Risk factor
Poor trading liquidity
Profitability factor
Excellent dividends
About
PT Industri Jamu dan Farmasi Sido Muncul Tbk is an Indonesian enterprise specializing in the production and distribution of herbal remedies, cosmetics, and health-focused food and beverage items. Its operations are divided into three primary segments: Herbal Medicine and Supplements, Food and Beverage, and Pharmacy. The company offers a comprehensive range of both ethical (prescription) and over-the-counter products, addressing a vast array of health concerns such as pain management, immune system support, cardiovascular health, digestive wellness, skin conditions, and various other specific ailments. Beyond its core activities, Sido Muncul also engages in commercial ventures, land transportation, wastewater treatment, plantation management, and printing services. Established in 1940, the company is headquartered in Semarang, Indonesia, and operates as a subsidiary of PT Hotel Candi Baru.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, undervalued
Target Price
The average target price of SIDO.JK is 596 and suggests 67.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in